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Serum protein abnormalities can be responsible
for elevations of serum viscosity . When clinical disease results, this condition is termed hyperviscosity
syndrome. Immunoglobulin complexes are a prominent cause of this syndrome. The acute illness in a
patient with Sjogren's syndrome, IgG-IgG complexes, and serum hyperviscosity was described in a
previous report. 1 After subsequent five-year followup, it has become apparent that the acute hyperviscosity syndrome in this patient was but one phase of a
prolonged, perhaps life-long, illness. This five-year
follow-up, which included observation of the effects
of steroid therapy on the underlying disease process,
is the subject of this report .
Materials and Methods. Serum relative viscosity
was determined by the method of Fahey, Barth , and
Solomon,2 using freshly obtained serum at 37 C in an
Oswald viscometer (Induchem Glass Co., Vineland,
N. J.) of 5 ml capacity. Total protein concentration
of serum was determined by the biuret technique.
Serum protein electrophoresis was done on cellulose
acetate strips in the Beckman Microzone Cell, Model
R IOI (Beckman Instruments, Inc., Fullerton, Ca.).
These measurements along with the serum electrophoresis were used to calculate the gamma globulin in grams per hundred milliliters. Rheumatoid fac-
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tor titers were determined by the sensitized hum an
cell test as previously described .3
Sedimentation patterns of serum proteins were
determined with a Beckman Spinco Model E analytical ultracentrifuge equipped with electronic speed
control, rotor temperature indicator control, and
schlieren optics. Sera were diluted I :4 with PBS
(0.13M sodium chloride, 0.02M sod ium phosphate,
pH 7.4) and dialyzed against PBS overnight. Runs
were performed with standard and wedge double sector cells at 20 C and 60,000 rpm a nd photographs
were taken at 32 and 64 minutes after operating speed
was reached .
Case Report. The patient, a 56-year-old black
woman, has been seen repeatedly at the Medical College of Virginia Hospita ls during the past 49 years
(Table I). She presented first in 1927 because of abdominal pain and vaginitis which were apparen tly
attributable to gonorrhea. In 1934, she was treated
for secondary syphilis manifested by rash, condylomata, and a 4+ Wasserman reaction, although
previously the Wasserman test had been negative; she
has remained sero-fast. Alopecia developed in 1956
and chest pains, myalgias, and arthralgias were her
main complaints in 1963 . These unexpla ined pains
recurred in 1964 and in 1965. In 1966, after a fourmonth period of chest pain, an infiltrate in the left
lower lobe of the lung was detected by x-ray; the
white blood count was then 3500/ mm 3 • The pneumonic process, thought to b-e a viral pneumonia,
subsided uneventfully.
The patient was referred to the Arthritis C linic in
1967 because of a five-month history o f morning
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stiffness and persistent hand, shoulder, ankle, and
foot pain. There was obvious synovial thickening; a
rheumatoid factor test (sensitized human cell test)
was positive with a titer of I :640, an antinuclear
antibody (ANA) test was weakly positive, and lupus
erythematosus cell tests were negative. A diagnosis of
definite rh eumatoid arthritis by American Rheum atism Association criteria was made. In 1968, Sjogren's
syndrome evolved with dryness of the eyes and
mouth, parotid gland enlargement, progression of
arthritis, and a positive Schirmer's test. At that time,
the serum total protein was 8.0 gm% with 19.7%
gamma globulin.
Vertigo and recurrent nosebleed first occurred in
1969 when the total serum protein was 11 .2 gm%.
Hyperviscosity was first suspected and detected in
May, 1970, when headaches, blurred vision , further
nosebleeds, exertional dyspnea, and paroxysmal nocturn a l dyspnea occurred. The course of the acute
hyperviscosity syndrome associated with polyclonal
gammopathy, IgG-IgG complexes, and extraordinary titers of rheumatoid factors was presented in the
earlier report.' Since 197 i , the hyperviscosity syndrome has not recurred, but the clinical problems of
underlying connective tissue disease, recurrent infections, and steroid-induced complications including
aseptic necrosis of the femoral heads have remained .
Results. Throughout the five-year period from
1970 to 1975, there has been a r..emarkable correlation
between gamma globulin levels, rheumatoid factor
titers, serum viscosity, and ultracentrifuge patterns
(Fig I, Fig 2A and 2B). When globulin levels are high ,
rheumatoid factor titers and serum viscosity are also
elevated, and intermediate complexes become more
prominent in the analytical ultracentrifuge patterns.
Despite these parallel changes, it is apparent that the
hyperviscosity has not been a clinical problem in the
past four years. During this later period, the highest
recorded relative viscosity was 2. 7, a value not associated with h yperviscosity symptoms.
Management of this patient's illness has been
difficult. In the first phase of therapy, cyclophosphamide and penicillamine produced no apparent
benefit. 1 Since January, 1971 , prednisone has been
the only immunosuppressive agent used. There has
been an inverse correlation between prednisone dose
and laboratory evidence of serum protein abnormalities . This impressive effect of prednisone therapy
was most clearly apparent after the three periods in
which the patient decided to stop her medications .
The most prolonged period of interruption was the
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Table I
Medical Problems Prior to Hyperviscosity Syndrome at 51
Years of Age
Age

Date

8
13
15
25
28

1927
1932
1934
1944
1947

29-33
35-37

1948-53
1954-56

41

1960

42

1961

44

1963

45

1964

46
47
48

1965
1966
1967

49

1968

50

1969

51

1970

Medical Problems
Abdom ina l pain, etiology unknown
Tonsillitis
Secondary lues (syphilis)
Acute right cervical lymphadenitis
Right salpingo-oophorectomy,
appendectomy
Acute dacryocystitis
Alopecia, recurrent back pain,
epigastric pain
En larged right parotid, chronic
cervicitis
Pleurisy, hysterectomy, left
salpingo-oophorectomy
Hypertension, chronic bronchitis,
arthra lgi as
Total alopecia, periophthalmic
pigmentation, a rthra lgias
Pyelonephritis
Viral pneumonia
Subm ucous resection for right nasal
obstruction, seropositive
rheumatoid arthritis
Dry mouth , swelling of left parotid,
malar rash (Sjiigren's syndrome)
Sjiigren's syndrome, urina ry tract
infection, pleurisy, nosebleeds
Hyperviscosity syndrome, cirrhosis,
a lopecia

last three months of 1973. Although she had been
receiving only IO mg of prednisone daily, this dosage
was apparently effective in partially normalizing
serum protein a bnorm a lities. After three months
without therapy, rheum atoid factor titers, gamma
globulin levels, and serum viscosity clearly increased.
Again, intermediate complexes were prominent in
the sedimentation profile. (See pattern 1-7-74 in Fig
2B.) More recently, the prednisone dosage has been
maintained at 5 to IO mg daily with satisfactory
control of serum protein abno rmalities.
Discussion. The most striking features in this
case of Sjogren's syndrome have been the long-standing nature of the underlying disease process, the dramatic but relati vely short-lived hyperviscosity syndrome, and the effect of prednisone therapy.
Any relatio nship of earlier illnesses, including
syphilis, with a lo ng-standing sero-fast st ate to the
present connective tissue disease is problematical.
Alopecia, however, is almost certainly part of the
present disease. The alopecia was first noted in 1956,
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Fig I-Five-year documentation of clinical events and laboratory measurements in patient with hyperviscosity associated with Sjiigren 's
syndrome. Arrows refer to patterns on Fig 2A and 28.
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Fig 2A -Serum electrophoretic patterns and ultacentrifuge patterns of serum samples taken over a five-year period following hyperviscosity syndrome, Direction of sedimen tation is to the right Photographs taken on dates indicated at 60,000 rpm and 20 C.
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f'ig 28- Serum electrophoretic patterns and ultracentrifuge pa tterns of serum samples tak en over a five-year period fo llowing hyperviscosity syndrome. Direction of sedimenta tion is to the right. Pho tograph s taken on d a tes indicated at 60,000 rpm and 20 C.

11 years before she developed seropositive arthritis
and a positive ANA, and 13 years before the first
symptoms of hyperviscosity.
After approximately one year in which hyperviscosity symptoms dominated the clinical picture, the
patient has remained free of those symptoms for four
years. Thus, the dramatic clinical occurrence of a
hyperviscosity syndrome and attendant therapeutic

problems need not imply that the patient's basic illness is of recent origin or that the hyperviscosity
syndrome will be a persistent problem .
Prednisone therapy has been effective in the control of both serum protein abnormalities and symptoms of hyperviscosity. Probable side effects of steroids including aseptic necrosis of the femoral head
and infections have presented emphatic evidence that
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in this patient's case steroid therapy also has been
harmful. Despite these side effects, her current relative well-being indicates that the steroids are useful
therapeutically and that in long-term management
the dosage can and must be maintained at a low level.
The effectiveness of low dosage in this case may be
attributable in part to prolonged steroid action because of its abnormally slow metabolism by a cirrhotic liver. Cessation of prednisone therapy was rapidly reflected in increased levels of gamma globulins,
serum viscosity, and rheumatoid factor levels .
Pharmacologic effects of adrenal steroids on serum immunoglobulins and immunoglobulin metabolism in normal volunteers were reported by Butler
and co-workers.• A three- or five-day course of methylprednisolone, 96 mg daily, produced marked decreases in serum IgG levels which persisted for at
least three months. These effects were largely attributable to inhibition of IgG synthesis. Levels of IgA
were also decreased, but lgM was not affected. These
pharmacologic studies of steroid effects provide a
rationale for steroid usage in patients with undesirable effects of lgG , such as lgG -IgG complex formation.
The immunologic and physiochemical events
that presage and maintain the hyperviscosity syndrome are poorly understood. In 1968, our patient
had a normal electrophoretic pattern and a normal
percentage of gamma globulin. In 1969, the total
serum protein was found to be 11.2 gm% and nosebleeds were a recurrent problem. Hyperviscosity was
first suspected in 1970, when the full clinical pattern
of vertigo, headaches, blurred vision, and dyspnea
made their appearance.
Bjorneboe and Jensen 5 studied a case of myelomatosis with normal colloid osmotic pressure in
spite of extremely high serum protein concentration
and postulated that extremely high levels of protein
led to aggregation (complexing) of the protein molecules which in turn led to hyperviscosity. The studies
of Pope et al 6 on the hyperviscosity syndrome in
rheumatoid arthritis due to intermediate complexes
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formed by the self-association of IgG-rheumatoid
factors would seem to strengthen this concept. Our
study shows that the presence of intermediate complexes waxes and wanes with the level of immunoglobulins . In the samples from November and December, 1971, and January, 1972, there are practically no
demonstrable intermediate complexes in the patient's
serum; one of the lowest levels of gamma globulin
and with a viscosity of 1.8 occurred at the same time.
The possibility that intermediate complexes represent compensatory responses to maintain the osmotic equilibrium in face of extremely high levels of
globulins cannot be completely dismissed.
On the basis of the response of this patient, one
might recommend that the hyperviscosity syndrome
of connective tissue disease be managed initially with
plasmaphoresis, followed by long-term treatment
with progressively decreasing doses of ctdrenal steroids.
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